Bristol’s Taxol, Sanofi’s Taxotere Among Latest Victims Of China Price Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
China’s NDRC cuts retail ceiling prices on 95 cancer, hematology and immunology drugs, with more cuts expected next year.